Tara Deaver, DPM
Podiatrist · Odessa, TXNPI 1548207731
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 29 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Smith+Nephew at 30.2% of the total. Reporting peaked in 2022 at $549 and has fallen 70.9% since, to $160 in 2025. That places this record below the midpoint for podiatrist clinicians in TX, where the typical reported total is $1,991.
Across 29 payments — averaging $47.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$417
- Integra Lifesciences Corporation$231
- Sanara Medtech Inc.$206
- Innovation Technologies Inc$147
- Organogenesis Inc.$98
- Novo Nordisk$75
- plus $206 from 7 others
What the payments were for
- Food & beverage$1,380100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 14 | $417 |
| Integra Lifesciences Corporation | 2 | $231 |
| Sanara Medtech Inc. | 1 | $206 |
| Innovation Technologies Inc | 2 | $147 |
| Organogenesis Inc. | 1 | $98 |
| Novo Nordisk | 1 | $75 |
| Zimmer Biomet | 1 | $61 |
| Paratek Pharmaceuticals, Inc. | 1 | $60 |
| Bsn Medical Inc | 2 | $27 |
| AbbVie | 1 | $20 |
| Abbott | 1 | $19 |
| Lifenet Health | 1 | $17 |
| Advanced Oxygen Therapy Inc. | 1 | $2 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTEGRA$464
- CellerateRx$206
- INTEGRA DERMAL REGENERATION TEMPLATE$155
- PRIMATRIX$155
- Irrisept$123
- COLLAGENASE SANTYL$100
How this compares
$1,380 in reported general payments places this provider in the 40th percentile of 470 podiatrist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JubliaEfinaconazole | 14 | $21,840 |
| Clotrimazole | 24 | $616 |
| Terbinafine Hcl | 15 | $198 |
| Ciprofloxacin Hcl | 12 | $128 |
| Doxycycline Hyclate | 12 | $78 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Odessa
- Brian CarpenterFort Worth$1.2M
- Gary LepowHouston$1M
- Wayne HurstCedar Park$625K
- Calvin RushingSunnyvale$452K
- Alan GarrettFort Worth$185K
- Gregory JarygaFt Worth$175K
- Brandon LampeMesquite$154K
- Andrew SchneiderHouston$150K
- Patrick BriggsWebster$133K
- Richard AdamsGranbury$130K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.